iConnectHub

Login/Register

WeChat

For more information, follow us on WeChat

Connect

For more information, contact us on WeChat

Email

You can contact us info@ringiertrade.com

Phone

Contact Us

86-21 6289-5533 x 269

Suggestions or Comments

86-20 2885 5256

Top

India-based VAV to supply LatAM market with high-purity lipids

Source:VAV Lipids Release Date:2024-03-14 141
Personal CareRaw Materials & IngredientsFood & BeverageFood & Beverage Ingredients Industry UpdatesIngredients/Formulation
Add to Favorites
Biopharmaceutical company, VAV Lipids, will supply its high-purity lipid ingredients to pharmaceutical, nutraceutical and cosmetics manufacturers in Latin America

VAV Lipids, one of the world’s leading lipid manufacturers, has announced its foray into Latin America. The company will supply its high-purity lipid ingredients to pharmaceutical, nutraceutical and cosmetics manufacturers through reputed local distributors in Mexico, Brazil, Argentina, Peru, and Colombia.

 

The biopharmaceutical company headquartered in Mumbai, India manufactures plant phospholipids (LECIVA), egg phospholipids (LIPOVA), synthetic phospholipids and neutral lipids, APIs and specialty proteins.

 

VAV’s high-grade phospholipids and lecithins are functional ingredients in developing novel drugs and biologics delivery systems (NDDS) for vaccines, anesthesia and formulations, cancer therapy based on liposomes, and for treating several diseases.

 

VAV Lipids will introduce its entire range of products through the company’s distribution network in Latin America. The company will provide intense technical and marketing training to its distributors. Customers will get end-to-end technical support including technical assistance in selecting the proper grade of lecithins or phospholipids and guidance on formulations, applications, analytical procedures and stability.

 

Arun Kedia, Managing Director of VAV Lipids, said, “Our expansion into Latin America will boost our global presence significantly. It will also benefit the local pharmaceutical, nutraceutical, and cosmetics industries. The Latin American market is huge and is presently underserved. VAV Lipids will cater to this unmet demand for high-quality ingredients.”

 

Kedia estimates the potential for VAV’s products in the LatAm market to be over USD 50 million. He added the company aims to grow aggressively in this market to occupy a 40% market share in the next five years.

 

Presently, VAV Lipids exports 80% of its products to North America, Europe, and Asia.

 

VAV’s lipid production facility is EU GMP certified and conforms to the best global practices and world-class standards. The company follows the Occupational Safety and Health Administration (OSHA) standards and is on track to achieving Net Zero emissions status.

 

The company meets the standards and certifications in Latin America such as Pharma- EU-GMP, Nutra -FSSAI (Food Safety & Standards Authority of India), Cosmetics- COSMOS (Ecocert) and All - ISO 22000, Export Inspection Agency. VAV Lipids recently received a certificate of appreciation from United States Pharmacopeia (USP) for contributing to the standards-setting activities in lipid manufacturing.

Add to Favorites
You May Like